These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6149801)

  • 1. Vecuronium in renal failure.
    Bevan DR; Donati F; Gyasi H; Williams A
    Can Anaesth Soc J; 1984 Sep; 31(5):491-6. PubMed ID: 6149801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Atracurium: neuromuscular blockade in repeated administration].
    Kube D; Schuh FT
    Anaesthesist; 1985 Dec; 34(12):639-44. PubMed ID: 2869712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular block: atracurium and vecuronium compared and combined.
    Black TE; Healy TE; Pugh ND; Kay B; Harper NJ; Petts HV; Sivalingham T
    Eur J Anaesthesiol; 1985 Mar; 2(1):29-37. PubMed ID: 2862032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with ORG NC45 (norcuron) as the sole muscle relaxant.
    Williams A; Gyasi H; Melloni C; Bevan DR
    Can Anaesth Soc J; 1982 Nov; 29(6):567-72. PubMed ID: 6128068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of Org NC45 (norcuron) in patients with and without renal failure.
    Fahey MR; Morris RB; Miller RD; Nguyen TL; Upton RA
    Br J Anaesth; 1981 Oct; 53(10):1049-53. PubMed ID: 6117300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response curves for vecuronium during halothane and neurolept anaesthesia: single bolus versus cumulative method.
    Ording H; Skovgaard LT; Engbaek J; Viby-Mogensen J
    Acta Anaesthesiol Scand; 1985 Jan; 29(1):121-4. PubMed ID: 2858146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atracurium, vecuronium and pancuronium in end-stage renal failure. Dose-response properties and interactions with azathioprine.
    Gramstad L
    Br J Anaesth; 1987 Aug; 59(8):995-1003. PubMed ID: 2888477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition and urinary excretion of vecuronium bromide in anesthetized patients with normal renal function or renal failure.
    Bencini AF; Scaf AH; Sohn YJ; Meistelman C; Lienhart A; Kersten UW; Schwarz S; Agoston S
    Anesth Analg; 1986 Mar; 65(3):245-51. PubMed ID: 2869722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular blocking and autonomic effects of vecuronium and atracurium in the anaesthetized cat.
    Sutherland GA; Squire IB; Gibb AJ; Marshall IG
    Br J Anaesth; 1983 Nov; 55(11):1119-26. PubMed ID: 6139121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response relationships and neuromuscular blocking effects of vecuronium pancuronium during ketamine anaesthesia.
    Engbaek J; Ording H; Pedersen T; Viby-Mogensen J
    Br J Anaesth; 1984 Sep; 56(9):953-7. PubMed ID: 6147154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular blocking action of vecuronium in the dog and its reversal by neostigmine.
    Jones RS
    Res Vet Sci; 1985 Mar; 38(2):193-6. PubMed ID: 2860709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of pancuronium in renal failure: no recurarization.
    Bevan DR; Archer D; Donati F; Ferguson A; Higgs BD
    Br J Anaesth; 1982 Jan; 54(1):63-8. PubMed ID: 6275872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular and cardiovascular effects of pipecuronium.
    Foldes FF; Nagashima H; Nguyen HD; Duncalf D; Goldiner PL
    Can J Anaesth; 1990 Jul; 37(5):549-55. PubMed ID: 1973636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vecuronium: onset of effect and intubation conditions in comparison to pancuronium and suxamethonium].
    Engel B; Schuh FT
    Anaesthesist; 1985 Dec; 34(12):645-50. PubMed ID: 2869713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacokinetics and dynamics of vecuronium and pancuronium in anesthetized patients.
    Sohn YJ; Bencini AF; Scaf AH; Kersten UW; Agoston S
    Anesth Analg; 1986 Mar; 65(3):233-9. PubMed ID: 2869721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vecuronium-induced neuromuscular blockade during enflurane, isoflurane, and halothane anesthesia in humans.
    Rupp SM; Miller RD; Gencarelli PJ
    Anesthesiology; 1984 Feb; 60(2):102-5. PubMed ID: 6141748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromuscular and vagal blocking actions of pancuronium bromide, its metabolites, and vecuronium bromide (Org NC45) and its potential metabolites in the anaesthetized cat.
    Marshall IG; Gibb AJ; Durant NN
    Br J Anaesth; 1983 Aug; 55(8):703-14. PubMed ID: 6136285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between the continuous infusion of vecuronium and the intermittent administration of pancuronium and vecuronium.
    Noeldge G; Hinsken H; Buzello W
    Br J Anaesth; 1984 May; 56(5):473-7. PubMed ID: 6144316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromuscular blocking effects of vecuronium and pancuronium during halothane anaesthesia.
    Engbaek J; Ording H; Viby-Mogensen J
    Br J Anaesth; 1983 Jun; 55(6):497-500. PubMed ID: 6134535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precurarization with vecuronium and pancuronium in awake, healthy volunteers: the influence on neuromuscular transmission and pulmonary function.
    Engbaek J; Howardy-Hansen P; Ording H; Viby-Mogensen J
    Acta Anaesthesiol Scand; 1985 Jan; 29(1):117-20. PubMed ID: 2858145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.